Benzinga's Top #PreMarket Gainers

By: via Benzinga
Brainstorm Cell Therapeutics Inc.(NASDAQ: BCLI) shares jumped 46.85% to $6.99 in pre-market trading ahead of January 5 conference call ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.